This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://dx.doi.org/10.1097/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45265310
rdf:type
wikibase:Item
schema:description
artigo científico article scientifique مقالة علمية نشرت في مارس 2005 2005年学术文章 2005年學術文章 tieteellinen artikkeli tudományos cikk 2005年学术文章 vitenskapelig artikkel artikulong pang-agham научная статья vetenskaplig artikel articolo scientifico 2005年学术文章 wissenschaftlicher Artikel artikel ilmiah სამეცნიერო სტატია научни чланак 2005年學術文章 2005年學術文章 2005年学术文章 scientific article published in March 2005 artigo científico videnskabelig artikel мақолаи илмӣ bài báo khoa học naučni članak vedecký článok מאמר מדעי 2005 nî lūn-bûn 2005年の論文 wetenschappelijk artikel vědecký článek 2005年學術文章 2005年學術文章 artykuł naukowy মার্চ ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scienca artikolo artigo científico scientific article published in March 2005 teaduslik artikkel bilimsel makale articol științific artículu científicu artikull shkencor επιστημονικό άρθρο научна статия 2005年学术文章 2005년 논문 article científic наукова стаття, опублікована в березні 2005 artículo científico publicado en 2005 vitskapeleg artikkel научни чланак บทความทางวิทยาศาสตร์ scientific article published in March 2005 2005年学术文章 article scientific
p:P577
wds:Q45265310-19D68847-2000-49CB-9A1C-29FB5D138341
wdt:P577
2005-03-01T00:00:00Z
p:P407
wds:Q45265310-2244EFF0-151E-4BE1-A7BE-C79F51399279
wdt:P407
wd:Q1860
p:P2093
wds:Q45265310-45A0D9E5-882E-401F-91FD-8E0DD3925041 wds:Q45265310-5E89026C-00F7-4666-B9EC-44BC6CD33101 wds:Q45265310-60789577-9707-41E2-9A67-6370A9A44C42 wds:Q45265310-5A669C04-C7F6-4131-A1F4-FFB61E837E9E wds:Q45265310-8C4AE745-449B-4341-BBFE-B6CF8A64D208 wds:Q45265310-C2CCC7C7-7598-4A20-8DCB-1C3EBD326277 wds:Q45265310-B071FA0A-826E-4849-B1B6-D5CB5B00465D wds:Q45265310-DBF17F71-BDB3-483A-9338-77D12037792A wds:Q45265310-F429169C-F91B-407A-BF1B-9411BD5C058B wds:Q45265310-CDD88482-9A84-4DFA-A6CC-4B615CCE7111 wds:Q45265310-01DB66E5-2456-4947-BADE-8A92C8DCCDA8 wds:Q45265310-35DC9DFB-0F1A-45DC-BF55-C7740706FC74 wds:Q45265310-506CA415-CB87-49F4-8858-DCF5CF948111
wdt:P2093
Suoping Zhai Elizabeth Jones Serge Cremers William L Dahut William D Figg Allyson Parr Seth M Steinberg Michael C Cox Clara C Chen Yinong Liu Xiaowei Yang Philip Arlen David J Liewehr
rdfs:label
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases
skos:prefLabel
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases
schema:name
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases
p:P50
wds:Q45265310-BF27BAC6-A5AB-4BF2-92B5-DEB64DD6E36D
wdt:P50
wd:Q6137574
p:P1476
wds:Q45265310-0A7BB86A-A7B7-425A-9F5B-A4001E4E7F1C
wdt:P1476
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases
p:P304
wds:Q45265310-C564EFCB-A8E8-4617-9936-7D9EC35AF449
wdt:P304
790-796
p:P31
wds:Q45265310-8ADFCC86-CA2C-4AE6-9216-18E236EA4951
wdt:P31
wd:Q13442814
p:P921
wds:Q45265310-547D176D-4CC1-4429-A5D5-DFC93509E518
wdt:P921
wd:Q42824440
p:P698
wds:Q45265310-45F277B3-B835-4141-90CB-E930BCB6DCE4
wdtn:P698
n10:15711271
wdt:P698
15711271
p:P1433
wds:Q45265310-D20E9E92-09EB-4C26-A1A1-74EB550E63CC
wdt:P1433
wd:Q15709979
p:P433
wds:Q45265310-821AF2DF-6B7B-4721-A0FB-4A030113E796
p:P478
wds:Q45265310-42F56115-AB81-4974-B694-DE8BD002FB77
wdt:P433
3
wdt:P478
173
p:P356
wds:Q45265310-108EE222-4D8D-464E-A5C0-E59225D87A06
wdtn:P356
n7:01.JU.0000147013.09157.8E
wdt:P356
10.1097/01.JU.0000147013.09157.8E
p:P5875
wds:Q45265310-7A86E923-CEDC-41DA-9694-9D28AF94F78F
wdt:P5875
8022438